Psychedelics
Search documents
AtaiBeckley reports positive data supporting repeated dosing of BPL-003 in treatment-resistant depression patients
Proactiveinvestors NA· 2025-11-10 14:15
Core Insights - Proactive provides fast, accessible, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, mining, oil and gas, and emerging technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
Lisata Therapeutics advances certepetide, inks strategic alliances in Q3
Proactiveinvestors NA· 2025-11-06 21:42
Core Insights - Proactive provides fast, accessible, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, mining, oil and gas, and emerging technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
atai Life Sciences and Beckley Psytech complete strategic combination to form AtaiBeckley
Proactiveinvestors NA· 2025-11-05 13:45
Core Insights - Proactive provides fast, accessible, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, mining, oil and gas, and emerging technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
BioHarvest Sciences CEO discusses Saffron Tech partnership - ICYMI
Proactiveinvestors NA· 2025-11-01 13:17
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has a presence in key finance and investing hubs with bureaus and studios located in major cities such as London, New York, Toronto, Vancouver, Sydney, and Perth [2][3] Group 2 - The company is committed to using technology to enhance workflows and improve content production [4] - Proactive employs automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Nevis Brands expands Major cannabis beverage line to New Mexico and Arizona
Proactiveinvestors NA· 2025-10-30 13:06
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive's news team delivers insights across various sectors including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
Businesswire· 2025-10-29 10:30
Core Insights - Compass Pathways plc has appointed Dr. Jeffrey Jonas to its Board of Directors, effective immediately, bringing over 30 years of experience in pharmaceutical research and development, particularly in neuroscience [1][3][4] - Thomas Lönngren will retire from the Board at the end of December after more than six years of service, having contributed significantly to the company's achievements, including the advancement of the COMP360 program [2][3] Company Overview - Compass Pathways is a biotechnology company focused on accelerating patient access to evidence-based innovations in mental health, particularly through its investigational COMP360 synthetic psilocybin treatment [6][7] - The company aims to address the growing mental health crisis by developing transformative treatments for conditions that are not adequately addressed by existing therapies [5][6] Product Development - COMP360 has received Breakthrough Therapy designation from the US FDA and Innovative Licensing and Access Pathway designation in the UK for treatment-resistant depression [7] - The company is pioneering a new treatment paradigm aimed at achieving rapid and durable responses for patients with serious mental health conditions [6][7] Leadership and Expertise - Dr. Jonas has held various leadership roles in life sciences, including CEO of Sage Therapeutics and President of the Regenerative Medicine Division at Shire Pharmaceuticals, and has a strong background in psychiatric disorders and neuropsychopharmacology [3][4] - His extensive experience is expected to be beneficial as Compass Pathways works towards bringing COMP360 to market, pending regulatory approval [3][5]
atai Life Sciences closes $149.5M public offering, extending cash runway into 2029
Proactiveinvestors NA· 2025-10-21 12:59
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive adopts technology to enhance workflows and improve content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]
Atai Life Sciences And Beckley Psytech: Promising Emerging Leader In Psychedelics
Seeking Alpha· 2025-10-20 13:00
Group 1 - The article does not provide any specific company or industry analysis, focusing instead on the author's qualifications and disclosures [1][2][3]
Do Silicon Valley Leaders Want Us on Drugs?
Medium· 2025-09-27 19:19
Core Insights - There is a growing interest in psychedelics among leaders in the AI and tech industry, suggesting a potential shift in perception towards these substances as beneficial for mental health [1][2] - The current revival of psychedelics is primarily driven by influential figures in Silicon Valley, marking a departure from the historical association with Hollywood [2] Group 1: Industry Trends - The 1950s saw early pro-LSD propaganda, with notable endorsements from celebrities, indicating a historical precedent for the acceptance of psychedelics as a mental health solution [1] - Today, Silicon Valley has emerged as the new hub for psychedelic advocacy, with tech leaders exploring their transformative potential [2] Group 2: Key Figures - Sam Altman, co-founder of ChatGPT and CEO of OpenAI, exemplifies the new wave of tech leaders who advocate for psychedelics, claiming a personal transformation after their use [3] - Altman's experience highlights a broader narrative among tech leaders who view psychedelics as a means to enhance mental well-being and creativity [3]
atai Life Sciences secures NIH grant for opioid use disorder program
Proactiveinvestors NA· 2025-09-18 12:52
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Group 2 - The company is focused on sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4] - Automation and software tools, including generative AI, are used, but all content is edited and authored by humans [5]